BIOMAT Database Logo BIOMAT Database Logo

Hyaluronan inhibits TLR-4 dependent cathepsin K and matrix metalloproteinase 1 expression in human fibroblasts. 2013

Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya 466-8550, Japan.

Rheumatoid synovial fibroblasts (RSF) are activated by toll-like receptor (TLR) signaling pathways during the pathogenesis of rheumatoid arthritis (RA). Cathepsin K is highly expressed by RSF, and is known to play a key role in the degradation of type I and type II collagen. Cathepsin K is considered to be implicated in the degradation of bone and cartilage in RA. Recent observations have shown that hyaluronan (HA) is an important inhibitor of inflammation. In the present study, we show that lipopolysaccharide (LPS) stimulation significantly increases cathepsin K expression by real-time PCR and western blotting analysis via a TLR-4 signaling pathway. Furthermore, we demonstrate that HA suppresses LPS-induced cathepsin K expression, which is dependent on CD44 but not intercellular adhesion molecule-1 (ICAM-1) interaction. We also show that HA suppresses LPS-induced matrix metalloproteinase-1 (MMP-1) expression, which is dependent on both CD44 and ICAM-1 interaction. We conclude that the anti-inflammatory effect of HA occurs through crosstalk between more than one HA receptor. Our study provides evidence for HA mediated suppression of LPS-induced cathepsin K and MMP-1 expression, supporting a protective effect of HA in RA.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006820 Hyaluronic Acid A natural high-viscosity mucopolysaccharide with alternating beta (1-3) glucuronide and beta (1-4) glucosaminidic bonds. It is found in the UMBILICAL CORD, in VITREOUS BODY and in SYNOVIAL FLUID. A high urinary level is found in PROGERIA. Amo Vitrax,Amvisc,Biolon,Etamucine,Healon,Hyaluronan,Hyaluronate Sodium,Hyvisc,Luronit,Sodium Hyaluronate,Acid, Hyaluronic,Hyaluronate, Sodium,Vitrax, Amo
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D051197 Toll-Like Receptor 4 A pattern recognition receptor that interacts with LYMPHOCYTE ANTIGEN 96 and LIPOPOLYSACCHARIDES. It mediates cellular responses to GRAM-NEGATIVE BACTERIA. TLR4 Receptor,Toll-4 Receptor,Receptor, TLR4,Toll 4 Receptor,Toll Like Receptor 4
D056657 Cathepsin K A cysteine protease that is highly expressed in OSTEOCLASTS and plays an essential role in BONE RESORPTION as a potent EXTRACELLULAR MATRIX-degrading enzyme.
D020781 Matrix Metalloproteinase 1 A member of the metalloproteinase family of enzymes that is principally responsible for cleaving FIBRILLAR COLLAGEN. It can degrade interstitial collagens, types I, II and III. Interstitial Collagenase,MMP-1 Metalloproteinase,MMP1 Metalloproteinase,Matrix Metalloproteinase-1,Pro-Matrix Metalloproteinase-1,Promatrixmetalloproteinase-1,proMMP-1,MMP 1 Metalloproteinase,Metalloproteinase 1, Matrix,Metalloproteinase, MMP-1,Metalloproteinase, MMP1,Metalloproteinase-1, Pro-Matrix,Pro Matrix Metalloproteinase 1,Promatrixmetalloproteinase 1

Related Publications

Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines.
June 2003, The Journal of rheumatology,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
WITHDRAWN:2',4',7-Trihydroxyisoflavon (THF) inhibits heat-shock-induced matrix metalloproteinase-1 expression in human dermal fibroblasts.
May 2006, Phytomedicine : international journal of phytotherapy and phytopharmacology,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Vitamin D Inhibits Expression and Activity of Matrix Metalloproteinase in Human Lung Fibroblasts (HFL-1) Cells.
August 2014, Tuberculosis and respiratory diseases,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Extracellular β-NAD(+) inhibits interleukin-1-induced matrix metalloproteinase-1 and -3 expression on human gingival fibroblasts.
January 2013, Connective tissue research,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.
February 2004, Journal of periodontology,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
4-Methylumbelliferone induces the expression of membrane type 1-matrix metalloproteinase in cultured human skin fibroblasts.
November 2002, Biochemical and biophysical research communications,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Trans-Zeatin inhibits UVB-induced matrix metalloproteinase-1 expression via MAP kinase signaling in human skin fibroblasts.
April 2009, International journal of molecular medicine,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells.
September 2000, Hypertension (Dallas, Tex. : 1979),
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Amentoflavone inhibits UVB-induced matrix metalloproteinase-1 expression through the modulation of AP-1 components in normal human fibroblasts.
March 2012, Applied biochemistry and biotechnology,
Shinya Hirabara, and Toshihisa Kojima, and Nobunori Takahashi, and Masahiro Hanabayashi, and Naoki Ishiguro
Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis.
August 2009, Annals of the rheumatic diseases,
Copied contents to your clipboard!